Medical Device Network on MSN
Stryker agrees to acquire IVL developer Amplitude Vascular Systems
Amplitude Vascular’s lead development product is an intravascular lithotripsy platform for calcified peripheral artery disease treatment.
Coronary Artery Disease (CAD) is the most common heart disease and most frequent cause of death in the U.S., with over 20 million adults affected by this condition Abbott’s investigational Coronary ...
Stryker (NYSE:SYK), a global leader in medical technologies, announced that it has signed a definitive agreement to acquire Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology ...
SYK to acquire Amplitude Vascular Systems, adding next-gen IVL tech to boost its peripheral vascular portfolio and expand ...
VANCOUVER, BRITISH COLUMBIA, CANADA, February 5, 2026 /EINPresswire.com/ — The global Intravascular Lithotripsy (IVL) market is forecast to grow from just over $1.1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results